Canceled development of messenger RNA vaccines imperils the country’s capacity to quickly respond to a bioterror threat or new emerging pandemic.
Eli Lilly's pill candidate, orforglipron, led to 11% weight loss in a late-stage trial, far less than results from injectable obesity drugs.
Oncologists worry that HHS's cutoff of mRNA research could lead to a broader hostile posture towards using mRNA and hamper cancer treatments.
Acquiring Amedisys would add to UnitedHealth's home care and hospice operations, one of the health care giant's many businesses.
Scientists call mRNA technology safe and effective, say Kennedy's "unscientific and misguided" decision will hamper research and pandemic response.
Scientists uncover what makes "superagers" resilient to memory loss in a study that hints at new ways to protect against Alzheimer’s-related brain changes.
Slow codes are not only ethical in some circumstances — they might be essential in today’s conflict-ridden medical landscape.
My cousin is displaced in Gaza. But his familial Mediterranean fever remains, exacerbated by the war.
